High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy

The original publication included two errors. The first error was in the “Imaging protocol” section. The inspection instrument used was a 1.5-T MRI system (Signa HDe; GE Healthcare) with a dedicated phased-array breast coil. Second, the present study has no relationship with the National Natural Science Foundation of China (81670595) and the Qingpu District Health Committee (W2020-14). The above two grants should be removed from the Acknowledgments. The correct Acknowledgements are shown below: “The authors thank the breast cancer patients who voluntarily participated in this research study”. The corrections do not change the results or conclusions of this paper. The authors sincerely apologize for any inconvenience caused by unintentional negligence.